{"disease":{"id":"metastatic-lung-cancer-with-alk-ros1-fusion","name":"metastatic lung cancer with alk ros1 fusion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06781905","title":"Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}